Provided by Tiger Trade Technology Pte. Ltd.

Syndax Pharmaceuticals

22.72
-0.7750-3.30%
Volume:624.57K
Turnover:14.35M
Market Cap:2.00B
PE:-6.89
High:23.57
Open:23.57
Low:22.56
Close:23.49
52wk High:25.59
52wk Low:8.58
Shares:88.20M
Float Shares:74.69M
Volume Ratio:0.96
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2949
EPS(LYR):-3.2949
ROE:-161.82%
ROA:-27.25%
PB:31.00
PE(LYR):-6.89

Loading ...

Jun 26, 2025

Major Issues Report

Form 8-K - Current report
May 16, 2025

Major Issues Report

Form 8-K - Current report
May 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 03, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Feb 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 16, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2024

Major Issues Report

Form 8-K - Current report
Oct 18, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 01, 2024

Major Issues Report

Form 8-K - Current report